Since the passage of the Affordable Care Act in 2010, preventive medicine has become a major priority in the healthcare industry, The Atlantic reports. 

Adults in Denmark whose partner died had an increased risk of atrial fibrillation for up to a year after the death, according to a population-based, case-control study.

A population-based study in Israel found that people with a high body mass index (BMI) in late adolescence had an increased risk of death from cardiovascular causes in adulthood compared with adolescents with a lower BMI.

With the House Energy and Commerce Health Subcommittee meeting on April 19 to discuss payment reforms for physicians, medical societies offered advice on how to implement the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

A program implemented at an urban academic medical center in Connecticut reduced 30-day readmissions by 9.3 percent among high-risk discharge patients who were enrolled in Medicare. The rate fell short of the goal of reducing all-cause readmissions by 20 percent.

DalCor Pharmaceuticals has raised $150 million to launch a clinical trial involving a cholesterol drug (dalcetrapib) that did not prevent MI and strokes in a previous phase 3 trial, the Wall Street Journal reports. 

On May 20 and 21 in Charlotte, athletes with a previous cardiovascular disease diagnosis or cardiovascular risk factors will compete in the 2016 World Heart Games.

The FDA withdrew the approvals of statins in combination with Niaspan (niacin extended-release tablets) and Trilipix (fenofibric acid delayed-release capsules) on April 18.